statistiche ricercatore

FASANO, MAURO

Distribuzione geografica

Continente	#
NA - Nord America	18.959
EU - Europa	9.711
AS - Asia	5.674
SA - Sud America	531
AF - Africa	126
Continente sconosciuto - Info sul continente non disponibili	19
OC - Oceania	11
Totale	35.031

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	18.769
IT - Italia	4.466
SG - Singapore	1.924
UA - Ucraina	1.481
CN - Cina	1.154
DE - Germania	848
VN - Vietnam	841
SE - Svezia	765
TR - Turchia	716
HK - Hong Kong	649
FI - Finlandia	487
GB - Regno Unito	447
BR - Brasile	433
IE - Irlanda	389
FR - Francia	298
RU - Federazione Russa	219
IN - India	113
MX - Messico	90
CA - Canada	83
JP - Giappone	69
NG - Nigeria	51
BE - Belgio	49
BD - Bangladesh	47
PL - Polonia	44
ES - Italia	43
NL - Olanda	40
CZ - Repubblica Ceca	39
ZA - Sudafrica	35
AR - Argentina	32
KR - Corea	19
EU - Europa	18
PK - Pakistan	18
IQ - Iraq	17
AT - Austria	16
PE - Perù	15
CO - Colombia	10
LT - Lituania	10
SA - Arabia Saudita	10
VE - Venezuela	10
CH - Svizzera	9
CL - Cile	9
EC - Ecuador	9
ID - Indonesia	9
PH - Filippine	9
EG - Egitto	8
IL - Israele	8
RO - Romania	8
UZ - Uzbekistan	8
AU - Australia	7
DK - Danimarca	7
NP - Nepal	7
PT - Portogallo	7
PY - Paraguay	7
AE - Emirati Arabi Uniti	6
BG - Bulgaria	6
ET - Etiopia	6
HU - Ungheria	6
JO - Giordania	6
MA - Marocco	6
TN - Tunisia	6
DZ - Algeria	5
HR - Croazia	5
IR - Iran	5
MY - Malesia	5
OM - Oman	5
EE - Estonia	4
GR - Grecia	4
KZ - Kazakistan	4
NZ - Nuova Zelanda	4
TH - Thailandia	4
BO - Bolivia	3
KE - Kenya	3
LB - Libano	3
MD - Moldavia	3
NI - Nicaragua	3
SI - Slovenia	3
SV - El Salvador	3
UY - Uruguay	3
AM - Armenia	2
AZ - Azerbaigian	2
BH - Bahrain	2
CR - Costa Rica	2
DO - Repubblica Dominicana	2
HN - Honduras	2
JM - Giamaica	2
MM - Myanmar	2
NO - Norvegia	2
QA - Qatar	2
RS - Serbia	2
SY - Repubblica araba siriana	2
TW - Taiwan	2
AL - Albania	1
BS - Bahamas	1
CG - Congo	1
CI - Costa d'Avorio	1
GE - Georgia	1
GH - Ghana	1
GT - Guatemala	1
KW - Kuwait	1
LU - Lussemburgo	1
Totale	35.022

Salva come PNG Salva come JPEG

Città	#
Milan	2.917
Fairfield	2.486
Ashburn	1.546
Woodbridge	1.474
Chandler	1.265
Jacksonville	1.139
Singapore	1.101
Seattle	1.020
San Jose	1.007
Houston	1.005
Cambridge	887
Wilmington	857
Hong Kong	644
Ann Arbor	624
Dearborn	459
Princeton	406
Dublin	378
Dallas	370
Nyköping	335
Beijing	331
Izmir	329
The Dalles	317
Chicago	312
Boardman	277
Rome	251
Dong Ket	240
Como	230
Lauterbourg	182
Munich	180
San Mateo	149
Los Angeles	140
New York	133
Ho Chi Minh City	112
San Diego	110
Helsinki	104
Hanoi	97
Ogden	78
London	76
Santa Clara	76
Orem	67
Council Bluffs	63
Tokyo	62
São Paulo	58
Guangzhou	55
Hefei	52
Abuja	51
Mexico City	51
Brussels	49
Denver	42
Warsaw	40
Montreal	39
Buffalo	37
Chennai	36
Kunming	36
Salt Lake City	35
Turku	35
Washington	34
Stockholm	33
Verona	33
Nanjing	31
Poplar	30
Falls Church	29
Atlanta	28
Paris	28
Düsseldorf	27
Nanchang	27
Phoenix	27
Varese	27
Brooklyn	26
Johannesburg	25
Amsterdam	23
Frankfurt am Main	22
Olomouc	22
Shanghai	22
Norwalk	21
Ponte Lambro	21
Curitiba	20
Jinan	20
San Francisco	20
Elk Grove Village	19
Manchester	19
Berlin	18
Boston	18
Brno	17
Redmond	17
Edinburgh	16
Tianjin	16
Cavaria con Premezzo	15
Shenyang	15
Shenzhen	15
Tampa	15
Columbus	13
Da Nang	13
Hangzhou	13
Haiphong	12
Mumbai	12
Nuremberg	12
Pune	12
Redwood City	12
Toronto	12
Totale	25.359

Salva come PNG Salva come JPEG

Nome	#
Experimental setup for the identification of mitochondrial protease substrates by shotgun and top-down proteomics	405
Changes in the two-dimensional electrophoresis pattern of the Parkinson's disease related protein DJ-1 in human SH-SY5Y neuroblastoma cells after dopamine treatment	373
Dopamine induces mitochondrial depolarization without activating PINK1-mediated mitophagy	288
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex	277
A meta-analysis of two-dimensional electrophoresis pattern of the Parkinson's disease-related protein DJ-1	275
Flavonoid binding to human serum albumin.	261
Mitochondrial Proteins in the Development of Parkinson’s Disease	254
Cellular models to investigate biochemical pathways in Parkinson's disease	248
Systems biology analysis of the proteomic alterations induced by MPP+, a parkinson's disease-related mitochondrial toxin	248
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex	246
Human serum albumin: from bench to bedside.	244
Evidence for pH-dependent multiple conformers in iron(II) heme-human serum albumin: spectroscopic and kinetic investigation of carbon monoxide binding.	239
Multiple isoforms and differential allelic expression of CHRNA5 in lung tissue and lung adenocarcinoma	235
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin	234
Ibuprofen binding to secondary sites allosterically modulates the spectroscopic and catalytic properties of human serum heme-albumin	233
Drugs modulate allosterically heme-fe-recognition by human serum albumin and heme-fe-mediated reactivity	232
Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulated.	230
Ibuprofen and warfarin modulate allosterically ferrous human serum heme-albumin nitrosylation.	229
Isoniazid and rifampicin inhibit allosterically heme binding to albumin and peroxynitrite isomerization by heme-albumin.	228
Allostery in a monomeric protein: the case of human serum albumin.	228
Verification of a parkinsons disease protein signature in T-lymphocytes by multiple reaction monitoring	222
Sequence analysis of serum albumins reveals the molecular evolution of ligand recognition properties.	221
Exploring the mitochondrial degradome by the TAILS proteomics approach in a cellular model of Parkinson's disease	219
All-trans-retinoic acid and retinol binding to the FA1 site of human serum albumin competitively inhibits heme-Fe(III) association	218
O2-mediated oxidation of ferrous nitrosylated human serum heme-albumin is limited by nitrogen monoxide dissociation.	217
H-1 NMR relaxometric characterization of bovine lactoferrin	217
Towards a functional definition of the mitochondrial human proteome	215
Lymphocyte proteomics of Parkinson's disease patients reveals cytoskeletal protein dysregulation and oxidative stress	214
Proteomics as a tool to investigate cell models for dopamine toxicity	213
Abacavir and warfarin modulate allosterically kinetics of NO dissociation from ferrous nitrosylated human serum heme-albumin	212
Proteome analysis of human substantia nigra in Parkinson's disease	212
Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease	210
Thermodynamic analysis of hydration in human serum heme-albumin.	210
Allosteric modulation of drug binding to human serum albumin	208
Reductive nitrosylation of ferric human serum heme-albumin.	207
Metal complexes as allosteric effectors of human hemoglobin: An NMR study of the interaction of the gadolinium(III) bis(m-boroxyphenylamide)diethylenetriaminepentaacetic acid complex with human oxygenated and deoxygenated hemoglobin	206
Altered dopamine homeostasis differentially affects mitochondrial voltage-dependent anion channels turnover	206
Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg).	205
Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration	204
Mitochondrial proteomics investigation of a cellular model of impaired dopamine homeostasis, an early step in Parkinson's disease pathogenesis	204
Systems biology analysis of the proteomic alterations in Parkinson's disease: Common and disease-specific pathways	204
Allosteric and binding properties of Asp1-Glu382 truncated recombinant human serum albumin - an optical and NMR spectroscopic investigation	203
Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease	202
A systems biology-led insight into the role of the proteome in neurodegenerative diseases	201
Mitochondrial alterations in Parkinson's disease human samples and cellular models	200
Demonstration of fibrinogen-FcRn binding at acidic pH by means of Fluorescence Correlation Spectroscopy	200
1H NMR RELAXOMETRIC AND OPTICAL ABSORBANCE CHARACTERIZAZION OF THE INTERACTION OF MANGANESE PORPHYRINS WITH HUMAN SERUM ALBUMIN	199
Proteomics and renaissance: accounts of the V Italian Proteomics Association Congress, Florence 2010.	199
Heme binding to albuminoid proteins is the result of recent evolution	198
Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies	198
Ligand binding to the FA3-FA4 cleft inhibits the esterase-like activity of human serum albumin	197
Proteomic characterization of Jurkat T leukemic cells after dopamine stimulation: A model of circulating dopamine-sensitive cells	196
AN NMR-STUDY OF THE INTERACTION BETWEEN MELANIN FREE ACID AND MN2+ IONS AS A MODEL TO MIMIC THE ENHANCED PROTON RELAXATION RATES IN MELANOTIC MELANOMA	195
Molecular phylogenetic analyses of albuminoids reveal the molecular evolution of allosteric properties	194
Method for the in vitro diagnosis of parkinson's disease	193
Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin	193
Diagnostic Salivary Tests for SARS-CoV-2	193
Ibuprofen modulates allosterically NO dissociation from ferrous nitrosylated human serum heme-albumin by binding to three sites.	192
Cellular response to empty and palladium-conjugated amino-polystyrene nanospheres uptake: A proteomic study	190
Deinococcus radiodurans' SRA-HNH domain containing protein Shp (Dr1533) is involved in faithful genome inheritance maintenance following DNA damage	190
PARAMAGNETIC GD-III-FE-III HETEROBIMETALLIC COMPLEXES OF DTPA-BIS-SALICYLAMIDE	188
Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies	188
Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study	188
Saliva is a reliable tool to detect SARS-CoV-2	186
Saggio rapido per la diagnosi in vitro di infezione da SARS-CoV-2 in un fluido biologico	185
Isolation and C-13-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease	184
Pseudo-enzymatic hydrolysis of 4-nitrophenyl myristate by human serum albumin.	184
Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients	183
Toward the Standardization of Mitochondrial Proteomics: The Italian Mitochondrial Human Proteome Project Initiative	183
SYNTHESIS AND CHARACTERIZATION OF A NOVEL DTPA-LIKE GADOLINIUM(III) COMPLEX - A POTENTIAL REAGENT FOR THE DETERMINATION OF GLYCATED PROTEINS BY WATER PROTON NMR RELAXATION MEASUREMENTS	182
The five-to-six-coordination transition of ferric human serum heme-albumin is allosterically-modulated by ibuprofen and warfarin: a combined XAS and MD study.	180
Abacavir modulates peroxynitrite-mediated oxidation of ferrous nitrosylated human serum heme-albumin	179
Parkinson's disease plasma biomarkers: An automated literature analysis followed by experimental validation	179
A new ytterbium chelate as contrast agent in chemical shift imaging and temperature sensitive probe for MR spectroscopy	178
Azide, cyanide, fluoride, imidazole and pyridine binding to ferric and ferrous native horse heart cytochrome c and to its carboxymethylated derivative: A comparative study	178
Digital and analogical reality in proteomics investigation	178
1H-NMR relaxometric analysis of drug binding effects to global unfolding of human serum albumin.	177
EVIDENCE FOR A GLYCIDIC-LIPIDIC MATRIX IN HUMAN NEUROMELANIN, POTENTIALLY RESPONSIBLE FOR THE ENHANCED IRON SEQUESTERING ABILITY OF SUBSTANTIA-NIGRA	177
Alpha-synuclein and Parkinson's disease: a proteomic view	177
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis	177
Integrative proteomics: perspective in complex system interpretation.	177
Mn(II) binding to human serum albumin: A (1)H-NMR relaxometric study.	177
Serum heme-albumin: an allosteric protein.	174
H-1-NMR relaxometric study of pancreatic serine (pro)enzyme inhibition by a Gd(III) chelate bearing boronic functionalities	173
Stabilization of the T-state of human hemoglobin by proflavine, an antiseptic drug	173
Prototropic and water-exchange processes in aqueous solutions of Gd(III) chelates	173
Prevention and modulation of aminoglycoside ototoxicity (Review)	173
Ibuprofen impairs allosterically peroxynitrite isomerization by ferric human serum heme-albumin.	173
Warfarin inhibits allosterically the reductive nitrosylation of ferric human serum heme-albumin	172
The drug-dependent five- to six-coordination transition of the heme-Fe atom modulates allosterically human serum heme-albumin reactivity	172
Sviluppo di un modello cellulare della disfunzione mitocondriale nella malattia di Parkinson nella linea cellulare SH-SY5Y in seguito a trattamento con dopamina o MPP+ ed analisi proteomica dei profili di espressione proteica dei mitocondri in modelli di patologie neurodegenerative.	171
Metodo per la diagnosi in vitro della malattia di Parkinson	170
Looking at COVID-19 from a Systems Biology Perspective	170
Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells	169
NMR-STUDIES OF MELANINS - CHARACTERIZATION OF A SOLUBLE MELANIN FREE ACID FROM SEPIA INK	166
Heme-based catalytic properties of human serum albumin	165
Reversible two-step unfolding of heme-human serum albumin: a H-1-NMR relaxometric and circular dichroism study	163
A cellular model of dopamine-dependent cell toxicity in Parkinson’s disease	163
Biomarkers of Parkinson’s disease	163
H-1 and O-17-NMR relaxometric investigations of paramagnetic contrast agents for MRI. Clues for higher relaxivities	161
Totale	20.413

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	131.026
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	131.026

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	1.099	0	0	0	0	0	0	0	0	0	221	320	558
2021/2022	2.362	300	403	166	84	109	77	145	114	113	308	211	332
2022/2023	3.277	311	194	268	345	224	645	10	459	484	118	137	82
2023/2024	4.722	751	762	748	838	931	248	34	148	114	25	20	103
2024/2025	3.381	18	44	587	98	111	187	162	282	366	410	275	841
2025/2026	6.713	449	456	305	974	825	438	1.558	448	946	314	0	0
Totale													35.161